ImpediMed Limited (ASX:IPD)
Australia
· Delayed Price · Currency is AUD 0.0340
+0.0010 (3.03%)
Apr 24, 2025, 4:10 PM AEST
ImpediMed Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 11.54 | 10.32 | 11.34 | 10.5 | 8.35 | 5.69 | Upgrade
|
| Other Revenue | - | - | - | 0.07 | 0.06 | 0.05 | Upgrade
|
| Revenue | 11.54 | 10.32 | 11.34 | 10.57 | 8.41 | 5.74 | Upgrade
|
| Revenue Growth (YoY) | 10.22% | -9.04% | 7.36% | 25.65% | 46.47% | 38.14% | Upgrade
|
| Cost of Revenue | 1.4 | 1.31 | 1.55 | 1.71 | 1.55 | 1.68 | Upgrade
|
| Gross Profit | 10.14 | 9.01 | 9.8 | 8.86 | 6.86 | 4.06 | Upgrade
|
| Selling, General & Admin | 23.62 | 26.15 | 25.29 | 23.67 | 24.55 | 21.97 | Upgrade
|
| Research & Development | 0.22 | 0.22 | 0.6 | 0.68 | 1.46 | 3.31 | Upgrade
|
| Other Operating Expenses | 4.67 | 4.42 | 4.31 | 3.2 | 2.12 | 4.3 | Upgrade
|
| Operating Expenses | 33.38 | 33.04 | 32.66 | 30.32 | 29.82 | 29.57 | Upgrade
|
| Operating Income | -23.24 | -24.04 | -22.87 | -21.47 | -22.97 | -25.51 | Upgrade
|
| Interest Expense | -0.08 | -0.09 | -0.03 | -0.03 | -0.05 | -0.07 | Upgrade
|
| Interest & Investment Income | 1.16 | 1.56 | 0.8 | 0.05 | 0.02 | 0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.82 | 2.82 | 1.61 | 1.62 | 1.79 | 4.14 | Upgrade
|
| EBT Excluding Unusual Items | -19.35 | -19.76 | -20.49 | -19.83 | -21.21 | -21.33 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.05 | - | Upgrade
|
| Other Unusual Items | -1.84 | - | - | - | 0.59 | - | Upgrade
|
| Pretax Income | -21.19 | -19.76 | -20.49 | -19.83 | -20.67 | -21.33 | Upgrade
|
| Income Tax Expense | 0.02 | 0.03 | 0.03 | 0.05 | 0.04 | 0.05 | Upgrade
|
| Earnings From Continuing Operations | -21.22 | -19.79 | -20.52 | -19.87 | -20.71 | -21.38 | Upgrade
|
| Net Income | -21.22 | -19.79 | -20.52 | -19.87 | -20.71 | -21.38 | Upgrade
|
| Net Income to Common | -21.22 | -19.79 | -20.52 | -19.87 | -20.71 | -21.38 | Upgrade
|
| Shares Outstanding (Basic) | 3,502 | 2,022 | 1,800 | 1,679 | 1,202 | 595 | Upgrade
|
| Shares Outstanding (Diluted) | 3,502 | 2,022 | 1,800 | 1,679 | 1,202 | 595 | Upgrade
|
| Shares Change (YoY) | -99.65% | 12.30% | 7.23% | 39.64% | 102.01% | 56.94% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | Upgrade
|
| Free Cash Flow | -18.29 | -17.87 | -18.44 | -15.72 | -13.32 | -19.31 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade
|
| Gross Margin | 87.88% | 87.27% | 86.37% | 83.83% | 81.54% | 70.77% | Upgrade
|
| Operating Margin | -201.33% | -232.95% | -201.56% | -203.16% | -273.12% | -444.35% | Upgrade
|
| Profit Margin | -183.82% | -191.78% | -180.90% | -188.09% | -246.24% | -372.36% | Upgrade
|
| Free Cash Flow Margin | -158.45% | -173.18% | -162.56% | -148.82% | -158.45% | -336.33% | Upgrade
|
| EBITDA | -21.61 | -23.46 | -22.32 | -20.23 | -22.61 | -25.05 | Upgrade
|
| EBITDA Margin | -187.25% | -227.31% | -196.73% | -191.46% | -268.91% | - | Upgrade
|
| D&A For EBITDA | 1.63 | 0.58 | 0.55 | 1.24 | 0.35 | 0.46 | Upgrade
|
| EBIT | -23.24 | -24.04 | -22.87 | -21.47 | -22.97 | -25.51 | Upgrade
|
| EBIT Margin | -201.33% | -232.95% | -201.56% | -203.16% | -273.12% | - | Upgrade
|
| Revenue as Reported | - | - | - | 10.56 | 8.41 | 5.74 | Upgrade
|
| Advertising Expenses | - | 0.52 | 0.46 | 0.67 | 0.45 | 0.88 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.